TY - JOUR
T1 - Renal replacement therapy in Europe
T2 - A summary of the 2011 ERA-EDTA Registry Annual Report
AU - European Renal Association–European Dialysis and Transplant Association (ERA-EDTA)
AU - Noordzij, Marlies
AU - Kramer, Anneke
AU - Abad Diez, José M.
AU - Alonso De La Torre, Ramón
AU - Arcos Fuster, Emma
AU - Bikbov, Boris T.
AU - Bonthuis, Marjolein
AU - Bouzas Caamaño, Encarnación
AU - Čala, Svetlana
AU - Caskey, Fergus J.
AU - Castro De La Nuez, Pablo
AU - Cernevskis, Harijs
AU - Collart, Frederic
AU - Díaz Tejeiro, Rafael
AU - Djukanovic, Ljubica
AU - Ferrer-Alamar, Manuel
AU - Finne, Patrik
AU - García Bazaga, María De Los Angelos
AU - Garneata, Liliana
AU - Golan, Eliezer
AU - Gonzalez Fernández, Raquel
AU - Heaf, James G.
AU - Hoitsma, Andries
AU - Ioannidis, George A.
AU - Kolesnyk, Mykola
AU - Kramar, Reinhard
AU - Lasalle, Mathilde
AU - Leivestad, Torbjørn
AU - Lopot, Frantisek
AU - Van De Luijtgaarden, Moniek W.M.
AU - Macário, Fernando
AU - Magaz, Ángela
AU - Martín Escobar, Eduardo
AU - De Meester, Johan
AU - Metcalfe, Wendy
AU - Ots-Rosenberg, Mai
AU - Palsson, Runolfur
AU - Piñera, Celestino
AU - Pippias, Maria
AU - Prütz, Karl G.
AU - Ratkovic, Marina
AU - Resić, Halima
AU - Rodríguez Hernández, Aurelio
AU - Rutkowski, Boleslaw
AU - Spustová, Viera
AU - Stel, Vianda S.
AU - Stojceva-Taneva, Olivera
AU - Süleymanlar, Gültekin
AU - Wanner, Christoph
AU - Jager, Kitty J.
PY - 2014/4
Y1 - 2014/4
N2 - BackgroundThis article provides a summary of the 2011 ERA-EDTA Registry Annual Report (available at www.era-edta-reg.org).MethodsData on renal replacement therapy (RRT) for end-stage renal disease (ESRD) from national and regional renal registries in 30 countries in Europe and bordering the Mediterranean Sea were used. From 27 registries, individual patient data were received, whereas 17 registries contributed data in aggregated form. We present the incidence and prevalence of RRT, and renal transplant rates in 2011. In addition, survival probabilities and expected remaining lifetimes were calculated for those registries providing individual patient data.ResultsThe overall unadjusted incidence rate of RRT in 2011 among all registries reporting to the ERA-EDTA Registry was 117 per million population (pmp) (n = 71.631). Incidence rates varied from 24 pmp in Ukraine to 238 pmp in Turkey. The overall unadjusted prevalence of RRT for ESRD on 31 December 2011 was 692 pmp (n = 425 824). The highest prevalence was reported by Portugal (1662 pmp) and the lowest by Ukraine (131 pmp). Among all registries, a total of 22 814 renal transplantations were performed (37 pmp). The highest overall transplant rate was reported from Spain, Cantabria (81 pmp), whereas the highest rate of living donor transplants was reported from Turkey (39 pmp). For patients who started RRT between 2002 and 2006, the unadjusted 5-year patient survival on RRT was 46.8% [95% confidence interval (CI) 46.6-47.0], and on dialysis 39.3% (95% CI 39.2-39.4). The unadjusted 5-year patient survival after the first renal transplantation performed between 2002 and 2006 was 86.7% (95% CI 86.2-87.2) for kidneys from deceased donors and 94.3% (95% CI 93.6-95.0) for kidneys from living donors.
AB - BackgroundThis article provides a summary of the 2011 ERA-EDTA Registry Annual Report (available at www.era-edta-reg.org).MethodsData on renal replacement therapy (RRT) for end-stage renal disease (ESRD) from national and regional renal registries in 30 countries in Europe and bordering the Mediterranean Sea were used. From 27 registries, individual patient data were received, whereas 17 registries contributed data in aggregated form. We present the incidence and prevalence of RRT, and renal transplant rates in 2011. In addition, survival probabilities and expected remaining lifetimes were calculated for those registries providing individual patient data.ResultsThe overall unadjusted incidence rate of RRT in 2011 among all registries reporting to the ERA-EDTA Registry was 117 per million population (pmp) (n = 71.631). Incidence rates varied from 24 pmp in Ukraine to 238 pmp in Turkey. The overall unadjusted prevalence of RRT for ESRD on 31 December 2011 was 692 pmp (n = 425 824). The highest prevalence was reported by Portugal (1662 pmp) and the lowest by Ukraine (131 pmp). Among all registries, a total of 22 814 renal transplantations were performed (37 pmp). The highest overall transplant rate was reported from Spain, Cantabria (81 pmp), whereas the highest rate of living donor transplants was reported from Turkey (39 pmp). For patients who started RRT between 2002 and 2006, the unadjusted 5-year patient survival on RRT was 46.8% [95% confidence interval (CI) 46.6-47.0], and on dialysis 39.3% (95% CI 39.2-39.4). The unadjusted 5-year patient survival after the first renal transplantation performed between 2002 and 2006 was 86.7% (95% CI 86.2-87.2) for kidneys from deceased donors and 94.3% (95% CI 93.6-95.0) for kidneys from living donors.
KW - end-stage renal disease
KW - incidence
KW - prevalence
KW - renal replacement therapy
KW - survival
UR - http://www.scopus.com/inward/record.url?scp=84897431514&partnerID=8YFLogxK
U2 - 10.1093/ckj/sfu007
DO - 10.1093/ckj/sfu007
M3 - Review article
AN - SCOPUS:84897431514
SN - 2048-8505
VL - 7
SP - 227
EP - 238
JO - Clinical Kidney Journal
JF - Clinical Kidney Journal
IS - 2
ER -